Celtic PLC Issue of Equity (5587X)

TIDMCCP

RNS Number : 5587X

Celtic PLC

31 August 2022

CELTIC PLC

Issued share capital

As a result of the issue of 34,979 Ordinary Shares of 1p each under the Company's scrip dividend reinvestment scheme on 31 August 2022, Celtic PLC's issued share capital as at 31 August 2022 was as follows:

 
 94,525,411    Ordinary Shares of 1p each ("Ordinary Shares") 
 12,718,393    Convertible Preferred Ordinary Shares of 100p each 
                ("CPO Shares") 
 15,797,424    Convertible Cumulative Preference Shares of 60p 
                each ("CCP Shares") 
 677,845,862   Deferred Shares of 1p each ("Deferred Shares") 
 

CCP Shares do not carry voting rights. Deferred Shares are not listed, are not transferable and carry no voting rights or substantive economic rights.

The above figures for Ordinary Shares and CPO Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in voting rights under the FCA's Disclosure Guidance and Transparency Rules.

The new Ordinary Shares of 1p each allotted under the scrip scheme have been issued at a notional price of 110p each.

Application has been made for the admission of the 34,979 new Ordinary Shares of 1p each arising from these conversions ("New Ordinary Shares") to trading on AIM. It is expected that dealings in these New Ordinary Shares, which will rank pari passu in all respects with the existing Ordinary Shares of the Company, will commence on 7 September 2022.

Enquiries:

Company

   Christopher Duffy, Company Secretary                    0141 551 4298 

Canaccord Genuity Limited

   Simon Bridges, Nominated Adviser                          0207 523 8350 

Thomas Diehl

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEDBLBXLVLFBBV

(END) Dow Jones Newswires

August 31, 2022 02:00 ET (06:00 GMT)